Medical Foam Market Report 2024

This Medical Foam market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The medical foam market size has grown strongly in recent years. It will grow from $31.03 billion in 2023 to $34.06 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The expansion observed in the past can be linked to the growing elderly population, advancements in healthcare, an increasing aging demographic, heightened focus on wellness, and a rise in the number of diabetics.

The medical foam market size is expected to see strong growth in the next few years. It will grow to $49.67 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The anticipated growth in the forecast period is driven by the rising number of surgical procedures, improvements in healthcare, the increasing prevalence of chronic and cardiovascular diseases, and higher disposable income. Key trends during this period include innovations in foam-based drug delivery systems, technological progress, the introduction of injection-molded titanium foam, advanced wound management methods, and the adoption of smart technologies.

The increasing prevalence of diabetes is expected to drive the growth of the medical foam market in the future. Diabetes is a chronic condition where the body either fails to produce sufficient insulin or cannot effectively use the insulin it produces, leading to elevated blood sugar levels and serious health complications if not properly managed. The rise in diabetes cases is linked to factors such as sedentary lifestyles, poor dietary habits, obesity, genetics, and an aging population. Medical foam plays a crucial role in diabetes care, particularly in treating diabetic ulcers by offering a protective barrier that absorbs exudate and aids in the healing process. For example, in June 2024, the National Health Service (NHS), a publicly funded healthcare system in England, reported that 3,615,330 people were registered with general practitioners as having non-diabetic hyperglycemia (pre-diabetes) in 2023, up from 3,065,825 in 2022 - an increase of nearly 18%. Thus, the growing prevalence of diabetes is fueling the demand for medical foam.

Key companies in the medical foam market are focusing on developing innovative materials, such as digital foam, to gain a competitive edge. Digital medical foam includes advanced foam dressings integrated with digital sensors to monitor wound conditions in real-time, improving wound care management. For instance, in October 2023, EOS GmbH, a Germany-based provider of industrial 3D printing solutions, introduced the DIGITAL FOAM Architects Network. This initiative allows for the design of customized foam structures with enhanced properties for medical applications and integrates smart technologies into foam products. This innovation improves functionality in areas such as wound care and prosthetics, advancing the medical foam sector by offering tailored solutions to meet specific healthcare needs.

In May 2023, Probo Medical, a U.S.-based company specializing in medical imaging equipment and repair services, acquired the MRI Coil Repair Operation of Creative Foam for an undisclosed sum. This acquisition was intended to strengthen Probo Medical's expertise in medical imaging repair, particularly in MRI coil repairs, thereby broadening its service offerings to healthcare providers. Creative Foam, the seller, is a U.S.-based company known for its medical foam products.

Major companies operating in the medical foam market are Bayer AG, 3M Company, Shin-Etsu Chemical Co. Ltd., Freudenberg Group, Avery Dennison Corp., Huntsman International LLC., Nitto Denko Corporation, Sonoco Products Company, FMC Biopolymer AS, Avient Corporation, Porex Corporation, Carpenter Co., FXI Holdings Inc., Rogers Corp., Armacell International Holding GmbH, Inoac Corporation, Future Foam, FoamPartner Group, General Plastics Manufacturing Company Inc., Recticel, Foamtec International, Technifoam.

North America was the largest region in the medical foam market in 2023. The regions covered in the medical foam market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical foam market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medical foam is a specialized foam used in healthcare for cushioning, wound care, and support. It is crafted to be durable, hypoallergenic, and often has antimicrobial properties, offering comfort, pressure relief, and protection for patients. Medical foam finds its applications in mattresses, padding for medical devices, dressings, and orthotic supports, enhancing patient care and recovery.

The primary types of medical foam include flexible foam, rigid foam, and spray foam. Flexible foam is soft and pliable, making it ideal for situations where comfort and cushioning are crucial. Various products include polyurethane (PU), polystyrene (PS), polyolefin, polyvinyl chloride (PVC), among others, and are used in applications such as bedding, medical packaging, medical devices and components, prosthetics, and wound care.

The medical foam market research report is one of a series of new reports that provides medical foam market statistics, including medical foam industry global market size, regional shares, competitors with a medical foam market share, detailed medical foam market segments, market trends and opportunities, and any further data you may need to thrive in the medical foam industry. This medical foam market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical foam market consists of sales of pressure ulcer pads, ostomy seals, surgical positioning pads, prosthetic liners, and splint padding. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.